BNP Paribas Asset Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.2M Buy
91,117
+30,487
+50% +$8.76M 0.06% 289
2025
Q1
$18.7M Buy
60,630
+2,854
+5% +$880K 0.05% 355
2024
Q4
$20.4M Buy
57,776
+25,684
+80% +$9.06M 0.05% 339
2024
Q3
$11.5M Buy
32,092
+12,566
+64% +$4.5M 0.03% 414
2024
Q2
$6.22M Buy
+19,526
New +$6.22M 0.02% 493
2023
Q3
Sell
-1,998
Closed -$441K 864
2023
Q2
$441K Buy
1,998
+1,069
+115% +$236K ﹤0.01% 788
2023
Q1
$208K Buy
+929
New +$208K ﹤0.01% 868
2022
Q3
Sell
-25,800
Closed -$6.08M 971
2022
Q2
$6.08M Buy
+25,800
New +$6.08M 0.02% 494
2019
Q2
Sell
-6,733
Closed -$790K 957
2019
Q1
$790K Buy
6,733
+61
+0.9% +$7.16K 0.01% 734
2018
Q4
$701K Buy
6,672
+377
+6% +$39.6K 0.01% 753
2018
Q3
$805K Sell
6,295
-5,848
-48% -$748K 0.01% 734
2018
Q2
$1.37M Sell
12,143
-7,394
-38% -$837K 0.01% 688
2018
Q1
$2.2M Buy
19,537
+11,269
+136% +$1.27M 0.02% 618
2017
Q4
$1.22M Buy
8,268
+2,480
+43% +$367K 0.01% 707
2017
Q3
$678K Buy
+5,788
New +$678K 0.01% 793
2017
Q2
Sell
-5,314
Closed -$719K 977
2017
Q1
$719K Sell
5,314
-3,597
-40% -$487K 0.01% 801
2016
Q4
$1.28M Sell
8,911
-2,570
-22% -$369K 0.01% 733
2016
Q3
$1.36M Buy
11,481
+9,250
+415% +$1.09M 0.01% 777
2016
Q2
$236K Sell
2,231
-13,041
-85% -$1.38M ﹤0.01% 1062
2016
Q1
$1.7M Sell
15,272
-9,733
-39% -$1.08M 0.01% 714
2015
Q4
$3.92M Buy
25,005
+935
+4% +$146K 0.03% 525
2015
Q3
$3.16M Sell
24,070
-246
-1% -$32.3K 0.03% 573
2015
Q2
$4.23M Buy
24,316
+22,123
+1,009% +$3.85M 0.03% 540
2015
Q1
$378K Buy
+2,193
New +$378K ﹤0.01% 950